MODULATION OF IMMUNE FUNCTION OCCURS WITHIN HOURS OF THERAPY INITIATION FOR MULTIPLE SCLEROSIS

Daily administration of FDA-approved glatiramer acetate (GA) has beneficial effects on clinical course of relapsing remitting multiple sclerosis (RRMS). Although mechanisms of GA-action have been widely investigated and partially understood, immediate immune dynamics following GA-therapy are unknown...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ayers, Chris L., Mendoza, Jason P., Sinha, Sushmita, Cunnusamy, Khrishen, Greenberg, Benjamin M., Frohman, Elliot M., Karandikar, Nitin J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634883/
https://ncbi.nlm.nih.gov/pubmed/23578552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2013.02.015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi